Trials / Conditions / Recurrent Merkel Cell Carcinoma
Recurrent Merkel Cell Carcinoma
5 registered clinical trials studyying Recurrent Merkel Cell Carcinoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Withdrawn | Veliparib, Capecitabine, and Temozolomide in Patients With Advanced, Metastatic, and Recurrent Neuroendocrine NCT02831179 | Vanderbilt-Ingram Cancer Center | Phase 1 |
| Active Not Recruiting | Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors NCT03074513 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Pembrolizumab in Treating Patients With Advanced Merkel Cell Cancer NCT02267603 | National Cancer Institute (NCI) | Phase 2 |
| Terminated | Viral Oncoprotein Targeted Autologous T Cell Therapy for Merkel Cell Carcinoma NCT01758458 | Fred Hutchinson Cancer Center | Phase 1 / Phase 2 |
| Completed | Cixutumumab, Everolimus, and Octreotide Acetate in Treating Patients With Advanced Low to Intermediate Grade N NCT01204476 | National Cancer Institute (NCI) | Phase 1 |